Skip to main content

Acticlate FDA Approval History

FDA Approved: Yes (First approved July 25, 2014)
Brand name: Acticlate
Generic name: doxycycline hyclate
Dosage form: Tablets
Company: Almirall, LLC
Treatment for: Bacterial Infection, Acne

Acticlate (doxycycline hyclate) is a tetracycline-class antibacterial indicated for the treatment of a number of infections, including adjunctive therapy in severe acne.

Development timeline for Acticlate

Jul 28, 2014Approval Aqua Pharmaceuticals Announces FDA Approval of Acticlate (doxycycline hyclate USP) Tablets

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.